Plain-English translation of NCT05689775 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is studying a new surgical approach for patients with advanced rectal or anal cancer. Surgeons use a robotic system to remove the cancer and then reconstruct the affected area using a flap of muscle from the patient's own abdomen. The study aims to understand how well this procedure works and how it affects patients' healing, quality of life, and sexual function over the first year.
Advanced rectal and anal cancers sometimes require removal of the rectum and surrounding tissue, which creates a large wound that needs to be filled. This trial is testing whether using a patient's own abdominal muscle (moved robotically) to reconstruct this area leads to better healing and fewer complications compared to standard approaches.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will have the standard robotic surgery for your cancer, plus the muscle flap reconstruction. After surgery, you will come back for study visits at 1 month, 6 months, and 12 months to check how your wound is healing. At these visits, you'll complete questionnaires about your quality of life and sexual health, and your surgeon will evaluate your abdominal wall strength. The study lasts about one year total.
AI-generated summary from trial data · Jul 15, 2026 · Not medical advice
Norway
Sponsor
Oslo University Hospital
Enrollment target
~40 participants
Started
September 2022
Primary completion
December 2024
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated on clinicaltrials.gov in January 2023.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Lars Frich, MD, PhD
Oslo University Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.